Search Results - Alexandre Avrameas

Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study Autoría: Thomas Dörner, Simon J. Bowman, Robert Fox, Xavier Mariette, Athena Papas, Thomas Grader‐Beck, Benjamin A. Fisher, Filipe Barcelos, Salvatore De Vita, Hendrik Schulze‐Koops, Robert J. Moots, Guido Junge, Janice Woznicki, Monika Sopala, Alexandre Avrameas, Wen‐Lin Luo, Wolfgang Hueber